Blue Owl Capital Holdings »

Lanzatech Global shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Lanzatech Global (LNZA) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Lanzatech Global

Tip: Access up to 7 years of quarterly data

All positions including Lanzatech Global held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lanzatech Global by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 2.9M 1.91

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Lanzatech Global

Novo A/S
BlackRock
BlackRock
Vanguard Group
Blue Owl Capital Holdings
Atalaya Capital Management
Invesco
Geode Capital Management
State Street Corporation
Northern Trust
Charles Schwab Investment Management
First Trust Advisors
Morgan Stanley
Bank of New York Mellon
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Lanzatech Global